526 related articles for article (PubMed ID: 34054510)
41. Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception.
Katsuyama S; Mizoguchi H; Kuwahata H; Komatsu T; Nagaoka K; Nakamura H; Bagetta G; Sakurada T; Sakurada S
Eur J Pain; 2013 May; 17(5):664-75. PubMed ID: 23138934
[TBL] [Abstract][Full Text] [Related]
42. β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.
Horváth B; Mukhopadhyay P; Kechrid M; Patel V; Tanchian G; Wink DA; Gertsch J; Pacher P
Free Radic Biol Med; 2012 Apr; 52(8):1325-33. PubMed ID: 22326488
[TBL] [Abstract][Full Text] [Related]
43. β-Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents.
He Y; Galaj E; Bi GH; Wang XF; Gardner E; Xi ZX
Br J Pharmacol; 2020 May; 177(9):2058-2072. PubMed ID: 31883107
[TBL] [Abstract][Full Text] [Related]
44. β-Caryophyllene nanoparticles design and development: Controlled drug delivery of cannabinoid CB2 agonist as a strategic tool towards neurodegeneration.
Alberti TB; Coelho DS; Maraschin M
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111824. PubMed ID: 33579467
[TBL] [Abstract][Full Text] [Related]
45. Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells.
Mannino F; Pallio G; Corsaro R; Minutoli L; Altavilla D; Vermiglio G; Allegra A; Eid AH; Bitto A; Squadrito F; Irrera N
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830893
[TBL] [Abstract][Full Text] [Related]
46. Combination of Imipramine, a sphingomyelinase inhibitor, and β-caryophyllene improve their therapeutic effects on experimental autoimmune encephalomyelitis (EAE).
Askari VR; Baradaran Rahimi V; Tabatabaee SA; Shafiee-Nick R
Int Immunopharmacol; 2019 Dec; 77():105923. PubMed ID: 31711937
[TBL] [Abstract][Full Text] [Related]
47. The cannabinoid receptor 2 agonist, β-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice.
Al Mansouri S; Ojha S; Al Maamari E; Al Ameri M; Nurulain SM; Bahi A
Pharmacol Biochem Behav; 2014 Sep; 124():260-8. PubMed ID: 24999220
[TBL] [Abstract][Full Text] [Related]
48. Pharmacological characterization of the cannabinoid receptor 2 agonist, β-caryophyllene on seizure models in mice.
Tchekalarova J; da Conceição Machado K; Gomes Júnior AL; de Carvalho Melo Cavalcante AA; Momchilova A; Tzoneva R
Seizure; 2018 Apr; 57():22-26. PubMed ID: 29547827
[TBL] [Abstract][Full Text] [Related]
49. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
50. Inhaled volatile β-caryophyllene is incorporated into the aortic wall and attenuates nicotine-induced aorta degeneration via a CB2 receptor-dependent pathway.
Kishi C; Higashihara M; Takemoto Y; Kamei M; Yoshioka Y; Matsumura S; Yamada K; Kobayashi T; Matahira Y; Moriyama T; Zaima N
Biomed Pharmacother; 2022 Sep; 153():113423. PubMed ID: 36076543
[TBL] [Abstract][Full Text] [Related]
51. The cannabinoid receptor 2 agonist, β-caryophyllene, improves working memory and reduces circulating levels of specific proinflammatory cytokines in aged male mice.
Lindsey LP; Daphney CM; Oppong-Damoah A; Uchakin PN; Abney SE; Uchakina ON; Khusial RD; Akil A; Murnane KS
Behav Brain Res; 2019 Oct; 372():112012. PubMed ID: 31173795
[TBL] [Abstract][Full Text] [Related]
52. Anti-inflammatory cannabinoids in diet: Towards a better understanding of CB(2) receptor action?
Gertsch J
Commun Integr Biol; 2008; 1(1):26-8. PubMed ID: 19704783
[TBL] [Abstract][Full Text] [Related]
53. β-Caryophyllene/Hydroxypropyl-β-Cyclodextrin Inclusion Complex Improves Cognitive Deficits in Rats with Vascular Dementia through the Cannabinoid Receptor Type 2 -Mediated Pathway.
Lou J; Teng Z; Zhang L; Yang J; Ma L; Wang F; Tian X; An R; Yang M; Zhang Q; Xu L; Dong Z
Front Pharmacol; 2017; 8():2. PubMed ID: 28154534
[TBL] [Abstract][Full Text] [Related]
54. Cannabinoid receptor 2‑selective agonist JWH015 attenuates bone cancer pain through the amelioration of impaired autophagy flux induced by inflammatory mediators in the spinal cord.
Mao Y; Huang Y; Zhang Y; Wang C; Wu H; Tian X; Liu Y; Hou B; Liang Y; Rong H; Gu X; Ma Z
Mol Med Rep; 2019 Dec; 20(6):5100-5110. PubMed ID: 31661120
[TBL] [Abstract][Full Text] [Related]
55. Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson's Disease Induced by MPTP.
Viveros-Paredes JM; González-Castañeda RE; Gertsch J; Chaparro-Huerta V; López-Roa RI; Vázquez-Valls E; Beas-Zarate C; Camins-Espuny A; Flores-Soto ME
Pharmaceuticals (Basel); 2017 Jul; 10(3):. PubMed ID: 28684694
[TBL] [Abstract][Full Text] [Related]
56. β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway.
Cheng Y; Dong Z; Liu S
Pharmacology; 2014; 94(1-2):1-12. PubMed ID: 25171128
[TBL] [Abstract][Full Text] [Related]
57. Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy.
Szczesniak AM; Porter RF; Toguri JT; Borowska-Fielding J; Gebremeskel S; Siwakoti A; Johnston B; Lehmann C; Kelly ME
Neuropharmacology; 2017 Feb; 113(Pt B):627-638. PubMed ID: 27569993
[TBL] [Abstract][Full Text] [Related]
58. Antidepressant-like effects of β-caryophyllene on restraint plus stress-induced depression.
Hwang ES; Kim HB; Lee S; Kim MJ; Kim KJ; Han G; Han SY; Lee EA; Yoon JH; Kim DO; Maeng S; Park JH
Behav Brain Res; 2020 Feb; 380():112439. PubMed ID: 31862467
[TBL] [Abstract][Full Text] [Related]
59. Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection.
Janecki M; Graczyk M; Lewandowska AA; Pawlak Ł
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456990
[TBL] [Abstract][Full Text] [Related]
60. Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.
Porter RF; Szczesniak AM; Toguri JT; Gebremeskel S; Johnston B; Lehmann C; Fingerle J; Rothenhäusler B; Perret C; Rogers-Evans M; Kimbara A; Nettekoven M; Guba W; Grether U; Ullmer C; Kelly MEM
Molecules; 2019 Sep; 24(18):. PubMed ID: 31540271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
